Clinical Trial Update: Multiple Dose Escalation Study (14 Days) to Investigate Safety, Tolerability, PK and PD of Vardenafil and BAY60-4552 [Phase 1]

View source ↗

Summary

Phase 1 multiple-dose escalation study in erectile dysfunction evaluating safety, tolerability, PK and PD of vardenafil and BAY60-4552; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction

Drugs mentioned

• BAY60-4552 (BAY60-4552)
• Vardenafil (vardenafil)

Snippet

Sponsor: Bayer | Conditions: Erectile Dysfunction | Phase 1 | Status: COMPLETED